Portfolio Update: Selling ADMA
I’m removing ADMA Biologics from the portfolio. The stock has delivered a solid gain for us — we’re exiting with a 46% profit at the current price of $14.73. I continue to believe in ADMA’s long-term…
I’m removing ADMA Biologics from the portfolio. The stock has delivered a solid gain for us — we’re exiting with a 46% profit at the current price of $14.73. I continue to believe in ADMA’s long-term…